5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Dermatology Associates of Rochester, P.C., Rochester

Virginia Commonwealth University, Richmond

Capitol Pediatrics & Adolescent Center, Raleigh

Allergy & Asthma Consultants, LLP, Charleston

Allergic Disease and Asthma Center, Greenville

The Pediatric Center, Stone Mountain

AeroAllergy Research Laboratories of Savanah, Inc., Savannah

Children's Skin Center, Miami

Pediatric Research Center of South Florida, Palm Beach Gardens

University of Tennessee - Dept. of Pediatrics, Memphis

Ohio Pediatrics, Inc., Huber Heights

Respiratory Medicine Research Institute of Michigan, Ypsilanti

Wayne State University Dermatology, Detroit

Michigan State University - Kalamazoo Center for Med Studies, Kalamazoo

Dermatology Center for Children, Minneapolis

University of Minnesota - Dept. of Dermatology, Minneapolis

SMDC Health System, Duluth

Radiant Research, Bridgeton

Arkansas Pediatric Clinic, Little Rock

Little Rock Allergy & Asthma Clinic, Little Rock

Suzanne Bruce& Associates, PA, Houston

Grand Parkway Pediatrics, Sugar Land

Longmont Clinical Research, Longmont

Phoenix Children's Hospital, Phoenix

Cholla Pediatrics, Tucson

9540 Artesia Blvd., Suite #1, Bellflower

Pediatric Care Medical Group, Inc., Huntington Beach

The Portland Clinic, Beaverton

Calcagno Research and Development, Gresham

Dermatology Research Associates, Cincinnati

Novartis, Investigative Site